LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,649,952 | +1.5% | 352,091 | +4.3% | 0.14% | -0.7% |
| Q2 2023 | $23,296,590 | +73.2% | 337,485 | +21.0% | 0.14% | +75.6% |
| Q1 2023 | $13,450,583 | -40.6% | 278,942 | -38.5% | 0.08% | -33.9% |
| Q4 2022 | $22,644,860 | -10.1% | 453,623 | -26.5% | 0.12% | -3.1% |
| Q3 2022 | $25,188,000 | -19.9% | 617,350 | +8.0% | 0.13% | -3.8% |
| Q2 2022 | $31,437,000 | +59.3% | 571,587 | +5.2% | 0.13% | +66.2% |
| Q1 2022 | $19,740,000 | +264.6% | 543,206 | +367.6% | 0.08% | +158.1% |
| Q4 2021 | $5,414,000 | – | 116,159 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |